• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素治疗的 2 型糖尿病患者低血糖发作频率与颈动脉粥样硬化变化的关系。

Relationship between frequency of hypoglycemic episodes and changes in carotid atherosclerosis in insulin-treated patients with type 2 diabetes mellitus.

机构信息

Department of Metabolism &Endocrinology, Juntendo University Graduate School of Medicine, Hongo 2-1-1, Bunkyo-ku, Tokyo 113-8421, Japan.

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan.

出版信息

Sci Rep. 2017 Jan 9;7:39965. doi: 10.1038/srep39965.

DOI:10.1038/srep39965
PMID:28067320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5220284/
Abstract

The effect of hypoglycemia on the progression of atherosclerosis in patients with type 2 diabetes mellitus (T2DM) remains largely unknown. This is a post hoc analysis of a randomized trial to investigate the relationship between hypoglycemic episodes and changes in carotid intima-media thickness (IMT). Among 274 study subjects, 104 patients experienced hypoglycemic episodes. Increases in the mean IMT and left maximum IMT of the common carotid arteries (CCA) were significantly greater in patients with hypoglycemia compared to those without hypoglycemia. Classification of the patients into three groups according to the frequency of hypoglycemic episodes showed that high frequency of hypoglycemic events was associated with increases in mean IMT-CCA, and left max-IMT-CCA and right max-IMT-CCA. In addition, repetitive episodes of hypoglycemia were associated with a reduction in the beneficial effects of sitagliptin on carotid IMT. Our data suggest that frequency of hypoglycemic episodes was associated with changes in carotid atherosclerosis.

摘要

低血糖对 2 型糖尿病(T2DM)患者动脉粥样硬化进展的影响在很大程度上尚不清楚。这是一项事后分析随机试验,旨在研究低血糖发作与颈动脉内膜中层厚度(IMT)变化之间的关系。在 274 名研究对象中,有 104 名患者出现低血糖发作。与无低血糖发作的患者相比,低血糖患者的颈总动脉(CCA)平均 IMT 和左侧最大 IMT 增加更明显。根据低血糖发作频率将患者分为三组,结果表明,低血糖事件的高频率与 CCA 平均 IMT、左侧最大 IMT-CCA 和右侧最大 IMT-CCA 的增加有关。此外,反复发生低血糖与西他列汀对颈动脉 IMT 的有益作用降低有关。我们的数据表明,低血糖发作的频率与颈动脉粥样硬化的变化有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef54/5220284/56978ed042e9/srep39965-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef54/5220284/56978ed042e9/srep39965-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef54/5220284/56978ed042e9/srep39965-f1.jpg

相似文献

1
Relationship between frequency of hypoglycemic episodes and changes in carotid atherosclerosis in insulin-treated patients with type 2 diabetes mellitus.胰岛素治疗的 2 型糖尿病患者低血糖发作频率与颈动脉粥样硬化变化的关系。
Sci Rep. 2017 Jan 9;7:39965. doi: 10.1038/srep39965.
2
Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial.西他列汀减缓胰岛素治疗的2型糖尿病患者颈动脉内膜中层增厚的进展:西他列汀内膜中层厚度评估预防研究(SPIKE):一项随机对照试验。
Diabetes Care. 2016 Mar;39(3):455-64. doi: 10.2337/dc15-2145. Epub 2016 Jan 28.
3
Differential effect of concomitant antidiabetic agents on carotid atherosclerosis: a subgroup analysis of the PROLOGUE study.联合使用的抗糖尿病药物对颈动脉粥样硬化的不同影响:PROLOGUE研究的亚组分析
Heart Vessels. 2019 Feb;34(2):375-384. doi: 10.1007/s00380-018-1275-5. Epub 2018 Oct 3.
4
Rosiglitazone and carotid IMT progression rate in a mixed cohort of patients with type 2 diabetes and the insulin resistance syndrome: main results from the Rosiglitazone Atherosclerosis Study.罗格列酮与2型糖尿病和胰岛素抵抗综合征混合队列患者的颈动脉内膜中层厚度进展率:罗格列酮动脉粥样硬化研究的主要结果
J Intern Med. 2007 Mar;261(3):293-305. doi: 10.1111/j.1365-2796.2007.01767.x.
5
Effect of sitagliptin on tissue characteristics of the carotid wall in patients with type 2 diabetes: a post hoc sub-analysis of the sitagliptin preventive study of intima-media thickness evaluation (SPIKE).西他列汀对 2 型糖尿病患者颈动脉壁组织特征的影响:西他列汀预防内中膜厚度评估研究(SPIKE)的事后亚分析。
Cardiovasc Diabetol. 2018 Feb 5;17(1):24. doi: 10.1186/s12933-018-0666-3.
6
Association between circulating leukocyte subtype counts and carotid intima-media thickness in Japanese subjects with type 2 diabetes.日本2型糖尿病患者循环白细胞亚型计数与颈动脉内膜中层厚度之间的关联。
Cardiovasc Diabetol. 2013 Dec 27;12:177. doi: 10.1186/1475-2840-12-177.
7
The Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled Trial.西他列汀对2型糖尿病患者颈动脉粥样硬化的影响:PROLOGUE随机对照试验
PLoS Med. 2016 Jun 28;13(6):e1002051. doi: 10.1371/journal.pmed.1002051. eCollection 2016 Jun.
8
Sitagliptin on carotid intima-media thickness in type 2 diabetes patients receiving primary or secondary prevention of cardiovascular disease: A subgroup analysis of the PROLOGUE study.西格列汀对接受心血管疾病一级或二级预防的 2 型糖尿病患者颈动脉内膜中层厚度的影响:PROLOGUE 研究的亚组分析。
Int J Cardiol. 2018 Nov 15;271:331-335. doi: 10.1016/j.ijcard.2018.05.055. Epub 2018 May 19.
9
Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A).阿格列汀,一种二肽基肽酶 4 抑制剂,可预防 2 型糖尿病患者颈动脉粥样硬化进展:阿格列汀预防糖尿病动脉粥样硬化研究(SPEAD-A)。
Diabetes Care. 2016 Jan;39(1):139-48. doi: 10.2337/dc15-0781. Epub 2015 Dec 1.
10
Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study.托格列净不会延缓 2 型糖尿病患者颈动脉粥样硬化的进展:一项前瞻性、随机、开放标签、平行组对照研究。
Cardiovasc Diabetol. 2020 Jul 9;19(1):110. doi: 10.1186/s12933-020-01079-4.

引用本文的文献

1
Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes.连续血糖监测指标与日本 2 型糖尿病患者动脉僵硬度的相关性。
Cardiovasc Diabetol. 2021 Jan 7;20(1):15. doi: 10.1186/s12933-020-01194-2.
2
Response: Differences in Clinical Outcomes between Patients with and without Hypoglycemia during Hospitalization: A Retrospective Study Using Real-World Evidence (Diabetes Metab J 2020;44:555-65).住院期间发生低血糖与未发生低血糖患者的临床结局差异:一项基于真实世界证据的回顾性研究(《糖尿病与代谢杂志》2020年;44:555 - 65)
Diabetes Metab J. 2020 Oct;44(5):779-780. doi: 10.4093/dmj.2020.0215. Epub 2020 Oct 21.
3

本文引用的文献

1
Inflammatory Biomarkers and Atherosclerosis.炎症生物标志物与动脉粥样硬化
Int Heart J. 2016;57(2):134-9. doi: 10.1536/ihj.15-346. Epub 2016 Mar 11.
2
Hypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated Diabetes.低血糖事件发生率:胰岛素治疗糖尿病的真实世界数据与随机对照试验人群的比较
Diabetes Ther. 2016 Mar;7(1):45-60. doi: 10.1007/s13300-016-0157-z. Epub 2016 Feb 17.
3
Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial.
Efficacy and safety of a combination of an insulin secretagogue and a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes mellitus; the repaglinide glucose oscillation study in Fukuoka (REGO-F).
胰岛素促泌剂与二肽基肽酶-4抑制剂联合用药对日本2型糖尿病患者的疗效及安全性;福冈瑞格列奈血糖波动研究(REGO-F)
Diabetol Int. 2020 Feb 14;11(3):274-282. doi: 10.1007/s13340-020-00426-w. eCollection 2020 Jul.
4
Hypoglycemia does not affect the progression of preclinical atherosclerosis in subjects with type 2 diabetes.低血糖不会影响 2 型糖尿病患者临床前动脉粥样硬化的进展。
PLoS One. 2019 Mar 5;14(3):e0212871. doi: 10.1371/journal.pone.0212871. eCollection 2019.
5
Dose-Dependent Effect of Sitagliptin on Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Post Hoc Analysis.西他列汀对接受胰岛素治疗的2型糖尿病患者颈动脉粥样硬化的剂量依赖性效应:一项事后分析
Diabetes Ther. 2017 Oct;8(5):1135-1146. doi: 10.1007/s13300-017-0309-9. Epub 2017 Sep 20.
西他列汀减缓胰岛素治疗的2型糖尿病患者颈动脉内膜中层增厚的进展:西他列汀内膜中层厚度评估预防研究(SPIKE):一项随机对照试验。
Diabetes Care. 2016 Mar;39(3):455-64. doi: 10.2337/dc15-2145. Epub 2016 Jan 28.
4
Progression of carotid-artery disease in type 2 diabetic patients: a cohort prospective study.2型糖尿病患者颈动脉疾病的进展:一项队列前瞻性研究。
Vasc Health Risk Manag. 2015 Oct 16;11:549-53. doi: 10.2147/VHRM.S79079. eCollection 2015.
5
Carotid intima-media thickness and hemodynamic parameters: reproducibility of manual measurements with Doppler ultrasound.颈动脉内膜中层厚度与血流动力学参数:多普勒超声手动测量的可重复性
Med Ultrason. 2015 Jun;17(2):167-74. doi: 10.11152/mu.2013.2066.172.ci-m.
6
Efficacy and safety of sitagliptin added to insulin in Japanese patients with type 2 diabetes: the EDIT randomized trial.在日本2型糖尿病患者中,西他列汀联合胰岛素治疗的疗效与安全性:EDIT随机试验
PLoS One. 2015 Mar 27;10(3):e0121988. doi: 10.1371/journal.pone.0121988. eCollection 2015.
7
Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study.胰岛素治疗 1 型和 2 型糖尿病患者的低血糖与心血管疾病和全因死亡率的风险:一项队列研究。
Diabetes Care. 2015 Feb;38(2):316-22. doi: 10.2337/dc14-0920. Epub 2014 Dec 9.
8
Repetitive hypoglycemia increases circulating adrenaline level with resultant worsening of intimal thickening after vascular injury in male Goto-Kakizaki rat carotid artery.反复性低血糖会使循环肾上腺素水平上升,导致雄性 Goto-Kakizaki 大鼠颈动脉血管损伤后的内膜增厚恶化。
Endocrinology. 2014 Jun;155(6):2244-53. doi: 10.1210/en.2013-1628. Epub 2014 Mar 31.
9
Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE).使用 DPP-4 抑制剂预防胰岛素治疗的 2 型糖尿病患者动脉粥样硬化的临床试验的原理、设计和基线特征:西他列汀内膜中层厚度评估(SPIKE)预防研究。
Diabetol Metab Syndr. 2014 Mar 10;6(1):35. doi: 10.1186/1758-5996-6-35.
10
Risk factors for the progression of intima-media thickness of carotid arteries: a 2-year follow-up study in patients with newly diagnosed type 2 diabetes.颈动脉内中膜厚度进展的危险因素:新诊断 2 型糖尿病患者的 2 年随访研究。
Diabetes Metab J. 2013 Oct;37(5):365-74. doi: 10.4093/dmj.2013.37.5.365. Epub 2013 Oct 17.